Angiodynamics Income Statement (2010-2026) | ANGO

Income Statement Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026
Revenue & cost
Revenue (Quarter)
76.84M76.97M78.28M73.97M87.00M81.54M85.43M80.71M91.07M78.68M79.07M75.18M70.98M67.49M72.84M72.00M80.16M75.71M79.43M78.42M
Cost of Revenue (Quarter)
23.82M36.83M23.61M35.39M82.02M39.23M26.01M25.41M-15.54M27.37M25.46M39.32M32.47M30.77M25.59M25.50M26.44M33.85M26.71M36.94M
Gross Profit (Quarter)
42.32M40.14M40.55M38.58M46.45M42.30M45.08M40.50M46.36M40.06M40.26M35.86M38.52M36.72M39.91M38.86M42.22M41.86M44.78M41.48M
Operating items
Amortization - Intangibles (Quarter)
4.30M4.82M4.90M4.90M4.86M4.80M4.81M4.70M4.40M3.62M3.56M3.30M2.50M2.57M2.60M2.60M2.60M2.65M2.60M2.70M
Research & Development (Quarter)
9.10M7.39M8.20M7.28M7.87M8.33M6.84M6.85M7.86M7.94M8.66M8.19M6.72M6.29M6.43M6.91M6.59M6.42M7.77M7.08M
Selling, General & Administrative (Quarter)
9.13M8.94M9.68M8.73M11.10M10.10M10.84M8.84M10.23M10.86M9.29M10.58M10.44M10.97M10.39M10.49M10.24M12.55M10.15M10.72M
Restructuring Costs (Quarter)
17.18M2.44M2.25M2.36M1.99M5.58M3.06M3.37M3.62M3.21M6.19M35.37M8.41M4.31M5.87M3.29M2.15M2.76M3.63M6.52M
Other Operating Expenses (Quarter)
28.50M29.46M29.10M25.51M31.89M47.84M6.66M30.78M29.35M30.11M
Operating Expenses (Quarter)
63.91M48.24M49.23M43.88M52.85M55.61M53.19M49.43M67.20M52.87M53.38M242.41M52.96M49.82M51.00M48.83M48.01M52.51M50.91M54.43M
Operating Income (Quarter)
-21.59M-8.10M-8.68M-5.29M-6.40M-13.30M-8.12M-8.93M-20.84M35.03M-13.12M-199.90M-14.45M-13.10M-11.09M-9.97M-5.79M-10.66M-6.12M-12.95M
EBIT (Quarter)
-21.59M-8.10M-8.68M-5.29M-6.40M-13.30M-8.12M-8.93M-20.84M35.03M-13.12M-199.90M-14.45M-13.10M-11.09M-9.97M-5.79M-10.66M-6.12M-12.95M
Non-operating items
Interest & Investment Income (Quarter)
0.12M0.53M0.39M0.57M0.61M0.23M0.14M0.00M-0.00M-0.10M-0.09M
Other Non Operating Income (Quarter)
-0.17M-0.35M-0.01M-0.29M-0.14M-0.17M-0.25M-0.13M-0.29M-0.03M-0.24M-0.26M-0.17M0.01M5.43M-0.33M-0.18M-0.13M4.97M
Non Operating Income (Quarter)
-1.03M-0.35M-0.01M-0.29M-0.32M-0.56M-0.25M-0.74M1.67M-0.29M-0.03M-0.24M-0.26M-0.17M0.25M5.57M-1.30M-0.18M-0.23M4.97M
Net income details
EBT (Quarter)
-21.94M-8.61M-8.86M-5.76M-6.72M-13.86M-9.05M-9.66M-21.86M34.86M-12.62M-199.74M-14.14M-12.66M-10.85M-4.41M-6.11M-10.84M-6.36M-8.07M
Tax Provisions (Quarter)
-2.47M-1.64M-0.51M-0.80M-0.46M-0.85M-0.56M-0.18M-0.40M-11.02M16.43M-12.00M-0.69M0.13M-0.11M-0.00M-0.06M0.07M-0.01M0.01M
Profit After Tax (Quarter)
-19.47M-6.97M-8.35M-4.96M-13.00M-13.00M-8.49M-9.48M-21.47M45.88M-29.05M-187.74M-13.45M-12.80M-10.74M-4.41M-6.05M-10.90M-6.35M-8.08M
Income from Continuing Operations (Quarter)
-19.47M-6.97M-8.35M-4.96M-6.27M-13.00M-8.49M-9.48M-21.47M45.88M-29.05M-187.74M-13.45M-12.80M-10.74M-4.41M-6.05M-10.90M-6.35M-8.08M
Consolidated Net Income (Quarter)
-19.47M-6.97M-8.35M-4.96M-6.27M-13.00M-8.49M-9.48M-21.47M45.88M-29.05M-187.74M-13.45M-12.80M-10.74M-4.41M-6.05M-10.90M-6.35M-8.08M
Income towards Parent Company (Quarter)
-19.47M-6.97M-8.35M-4.96M-6.27M-13.00M-8.49M-9.48M-21.47M45.88M-29.05M-187.74M-13.45M-12.80M-10.74M-4.41M-6.05M-10.90M-6.35M-8.08M
Net Income towards Common Stockholders (Quarter)
-19.47M-6.97M-8.35M-4.96M-6.27M-13.00M-8.49M-9.48M-21.47M45.88M-29.05M-187.74M-13.45M-12.80M-10.74M-4.41M-6.05M-10.90M-6.35M-8.08M
Additional items
EPS (Basic) (Quarter)
-0.50-0.18-0.21-0.13-0.16-0.33-0.21-0.24-0.541.15-0.72-4.67-0.33-0.31-0.26-0.11-0.15-0.26-0.15-0.19
EPS (Weighted Average and Diluted) (Quarter)
-0.50-0.18-0.21-0.13-0.16-0.33-0.21-0.24-0.541.15-0.72-4.67-0.33-0.31-0.26-0.11-0.15-0.26-0.15-0.19
Shares Outstanding (Weighted Average) (Quarter)
38.34M38.73M39.05M38.96M39.01M39.30M39.49M39.44M39.48M39.84M40.22M40.10M40.18M40.65M40.92M40.81M40.85M41.17M41.54M41.47M
Shares Outstanding (Diluted Average) (Quarter)
38.34M38.73M39.05M38.96M39.01M39.30M39.39M39.51M39.48M39.97M40.10M40.10M40.18M40.65M40.79M40.85M40.85M41.17M41.54M41.60M
EBITDA (Quarter)
-21.59M-8.10M-8.68M-5.29M-6.40M-13.30M-8.12M-8.93M-20.84M35.03M-13.12M-199.90M-14.45M-13.10M-11.09M-9.97M-5.79M-10.66M-6.12M-12.95M
Interest Expenses (Quarter)
0.18M0.16M0.17M0.17M0.18M0.38M0.68M0.74M0.90M-0.12M-0.53M-0.39M-0.57M
Tax Rate (Quarter)
11.26%19.01%5.78%13.88%6.77%6.16%6.24%1.85%1.82%-31.62%-130.21%6.01%4.89%-1.05%1.01%0.05%0.98%-0.60%0.08%-0.15%